Immediate Impact
1 by Nobel laureates 1 from Science/Nature 59 standout
Citing Papers
Phase 3 Open-Label Clinical Trial of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged 2–5 Years with Cystic Fibrosis and at Least One F508del Allele
2023 Standout
Pharmacologic improvement of CFTR function rapidly decreases sputum pathogen density, but lung infections generally persist
2023 Standout
Works of Robert L. Flucke being referenced
Forced Expiratory Flows and Volumes in Infants
2000
Adult-type pulmonary function tests in infants without respiratory disease
2000
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Robert L. Flucke | 611 | 34 | 16 | 185 | 108 | 9 | 665 | |
| A Barbato | 630 | 26 | 2 | 94 | 190 | 10 | 716 | |
| Tarek Nakhla | 554 | 104 | 225 | 27 | 14 | 764 | ||
| Marie-Denise Schaller | 378 | 49 | 5 | 121 | 74 | 10 | 575 | |
| Benjamin B. Ross | 500 | 40 | 16 | 73 | 225 | 14 | 648 | |
| David Henson | 312 | 14 | 5 | 100 | 78 | 17 | 846 | |
| Rebecca L. Mutich | 500 | 49 | 2 | 381 | 50 | 22 | 632 | |
| Robert G. Zwerdling | 546 | 12 | 2 | 339 | 30 | 15 | 696 | |
| R Ferranti | 394 | 74 | 79 | 73 | 13 | 602 | ||
| P. G. Fabricius | 449 | 23 | 3 | 88 | 263 | 14 | 682 | |
| Michael Davies | 583 | 14 | 6 | 62 | 221 | 21 | 766 |
All Works
Loading papers...